The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Maxibar 98.45% w/w powder for oral suspension

Bracco Imaging spaPA1826/002/001

Main Information

Trade NameMaxibar 98.45% w/w powder for oral suspension
Active SubstancesBarium sulfate
Dosage FormPowder for oral suspension
Licence HolderBracco Imaging spa
Licence NumberPA1826/002/001

Group Information

ATC CodeV08BA Barium sulfate containing X-ray contrast media
V08BA01 barium sulfate with suspending agents


License statusAuthorised
Licence Issued03/11/1992
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceRestricted to hospital dispensing
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back